Product Images Losartan Potassium

This is a description for Losartan Potassium tablets manufactured by Hetero Labs Limited in India. The tablets come in 50mg strength and are approved by NDC. The tablets should be stored at controlled room temperature and used as directed. The lot number and expiration date are provided for reference.*

The text is a statistical analysis report of a study that has been conducted. The findings suggest that there is an adjusted risk reduction of 26% with a p-value of 0.001. The graph shows the percentage of patients with first-line or fatal stroke over a period of 66 months.*

Figure 3 shows the primary endpoint events within demographic subgroups. The primary composite endpoint is stroke (fatal and non-fatal). The table presents the number of events for each subgroup, as well as the sample size. The treatment groups include Losartan and Atenolol. The symbols in the table are proportional to the sample size. There is additional illegible text present, so it is not possible to provide a complete description.*

The text "Risk Reduction = 0022 18.1% Months" suggests that there is a risk reduction associated with certain patents that has been quantified as 18.1%. The value "0022" could be a reference number or identifier. The word "Months" possibly indicates the time period over which the reduction was measured. It is not clear what "patents wih event" refers to.*